Summary:
Sonitus Medical and BHM have formed a strategic partnership to globally commercialize Sonitus’s bone conduction hearing products, combining innovation from China with BHM’s global marketing reach.
Key Takeaways:
- Global Expansion: BHM gains commercialization rights outside China for Sonitus’s two bone conduction hearing products, leveraging Med-El’s global network.
- Collaborative Development: The partnership includes joint efforts in product development, manufacturing, regulatory approval, marketing, and sales.
- Mutual Strengths: The alliance combines Sonitus’s innovation and Chinese supply chain advantages with BHM’s global brand presence to address unmet hearing needs worldwide.
Sonitus Medical has entered into a strategic cooperation with BHM, a European manufacturer of bone conduction hearing devices. The two companies will engage in deep collaboration across product development, manufacturing, regulatory approval, marketing, and sales.
Under the agreement, Sonitus Medical grants BHM the commercialization rights outside of China for two bone conduction hearing products developed by Sonitus. BHM, together with its parent company Med-El, a global implantable hearing solutions brand, will promote and distribute the products through Med-El‘s extensive marketing network, which spans more than 130 countries.
“The medical-grade bone conduction market for patients with conductive hearing loss, single-sided deafness, and mixed hearing loss is still in its infancy in China, but holds tremendous potential,” says Shawn Pu, chairman of Sonitus Medical. “In China, Sonitus Medical is already the leader in this niche segment. We are dedicated to developing innovative, high-quality, non-invasive bone conduction hearing solutions. Our products undergo rigorous clinical audiology validation and meet world-class standards. An increasing number of hearing-impaired individuals in China rely on Sonitus Medical’s products in their daily lives and work.”
“Even in relatively mature hearing markets like Europe and the United States, there remain many unmet needs among patients with conductive hearing loss, single-sided deafness, and mixed hearing loss,” adds Markus Hütter, managing director of BHM. “There is still significant growth potential for medical-grade bone conduction hearing devices, especially innovative and high-quality non-invasive solutions. Sonitus Medical is a dynamic and creative team with deep understanding and experience in medical-grade bone conduction. Through our collaboration, we hope to better leverage the efficiency, quality, and cost advantages of the Chinese supply chain, combined with our brand and marketing strengths in global markets—particularly the mature European and American markets—to offer patients newer and better solutions. I believe this is a truly win-win cooperation.”
For more information about Sonitus Medical and BHM, visit the Sonitus and BHM websites.
